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The function of saposin C (Sap C), a glucosylceramidase activator protein, in the enzyme stimulation by phosphatidylserine (PS) liposomes has 
been investigated. Using gel filtration experiments evidence was obtained for Sap C binding to PS large tmilamellar vesicles (LUV) but not to 
glucosylceramidase. PS LUV, which by themselves are unable to tightly bind and stimulate the enzyme, acquire the capacity to also bind the enzyme 
after interaction with Sap C, making it express its full activity. Our results indicate that the primary step in the Sap C mode of action resides in 
its association with PS membranes; in turn, this association promotes the interaction between the membranes and glucosylceramidase. 
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1. INTRODUCTION 
Glucosylceramidase (EC, 3.2.1.45) is the lysosomal 
enzyme which hydrolyses glucosylceramide to ceramide 
and glucose [1,2]. It has been reported that glucosylcer- 
amidase needs the assistance of a small glycoprotein 
cofactor, called saposin C (Sap C) or SAP-2, to attack 
glucosylceramide [336]. Actually, Gaucher’s disease, an 
autosomal recessive disorder characterized by gluco- 
sylceramide accumulation, can be caused either by a 
deficiency of glucosylceramidase or of Sap C [5,6]. 
vestigated. It has been proposed that PS and activator 
protein bind at two different sites of the enzyme for the 
activation [12,13]; Sap C forms a complex with gluco- 
sylceramidase but not with PS [13]. 
Sap C, together with saposins A,B and D, is derived 
from a single precursor protein [7,8]. The four saposins 
are structurally similar to each other. Saposin B stimu- 
lates the enzymatic hydrolysis of various sphingolipids, 
including sulfatide, GM1 ganglioside and globo- 
triaosylceramide; saposin A and C that of glucosylcer- 
amide and galactosylceramide and saposin D that of 
sphingomyelin [9,10]. 
In previous investigations on the interaction between 
acidic phospholipids and glucosylceramidase [14-l 61 we 
have shown that the enzyme activation occurs through 
the association of the enzyme with PS-containing li- 
posomes. The physical organization of the lipid surface 
is of critical importance for this association; actually, 
small PS vesicles tightly bind the enzyme, while large 
vesicles are unable to reconstitute glucosylceramidase 
U61. 
Glucosylceramidase is tightly bound to the lysosomal 
membrane; its activity is markedly impaired by delipi- 
dation and purification [4]. The purified enzyme can be 
reactivated by addition of acidic phospholipids, the re- 
constitution being facilitated by the presence of Sap C 
[4,111. 
In search for specific compounds that might have a 
role in the association of glucosylceramidase with mem- 
branes, we have investigated whether Sap C can pro- 
mote the reconstitution of fully active glucosylcerami- 
dase by PS LUV. This has led us to reexamine the 
interactions between the activator protein, the enzyme 
and the liposomes. 
2. MATERIALS AND METHODS 
2.1. Materials 
In vitro studies with glucosylceramidase, Sap C and 
acidic phospholipids are essential to understanding the 
physiological conditions for the enzyme action. The 
mechanism of glucosylceramidase activation by the 
combination of an acidic phospholipid such as phos- 
phatidylserine (PS) and Sap C has been extensively in- 
Sodium taurocholate (TC) (synthetic, > 98% pure), and 4-methy- 
lumbelliferyl-p-o-glucopyranoside (MUGlc) were from Sigma (St. 
Louis, MO, USA). Triton X-100 was from Pierce (Rockford, Illinois, 
USA). PS from bovine spinal cord was from Calbiochem (San Diego, 
CA, USA). 1,2-Dioleoyl-3-sn-phosphatidyl-L-[3-14C]ne (54 mCi/ 
mmol) was from Amersham International (UK). The other chemicals 
were of the purest available grade. 
*Corresponding author. Fax: (39) (6) 444 0078. 
2.2. Enzyme preparation 
Glucosylceramidase was purified from human placenta following 
the procedure described by Murray et al. [17]. 
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2.3. Saposin C preparation 
Sap C was purified from spleens of patients with Type 1 Gaucher 
disease. The isolation procedure was basically the same as that de- 
scribed for Sap C from guinea pig [18]. It consisted of hot-water 
extraction of spleen and consecutive column chromatographies with 
DEAE-cellulose, Sephadex G-75 and reverse-phase HPLC with a C4 
column (Vydac). The preparation was pure according to SDS-PAGE 
and Western blot analysis. The purity and identity of Sap C was 
confirmed by automated Edman degradation of the protein, per- 
formed with an Applied Biosystems model 476A gas-phase sequencer. 
2.4. SDS-PAGE and immunoblots 
SDS-PAGE was performed by the method of Laemmli with 15% 
acrylamide [19]. After electrophoresis the samples were electroblotted 
to PVDF (polyvinylidene difluoride) membrane (Bio-Rad, Richmond, 
USA) and detected with a monospecific antibody against Sap C (kind 
gift of Dr. D. Wenger, Jefferson University, Philadelphia) using a 
Vectastain ABC kit (Vector Labs, Burlingame, CA) according to the 
manufacturer’s instructions. 
2.5. Glucosylceramidase and Sap C assays 
The standard assay mixture used to measure glucosylceramidase 
activity contained, in a final volume of 0.2 ml: 0.1/0.2 M citrate/ 
phosphate buffer @H 5.6) 2.5 mM MUGlc, 0.1% (v/v) Triton X-100 
and 0.25% (w/v) TC. When the stimulatory capacity of PS and/or 
Sap C was evaluated, the assay mixture contained, in a final volume 
of 0.2 ml: 10 mM acetate buffer (pH 5.4), 150 mM NaCl, 1 mM 
dithioerythritol and 1 mM EDTA (buffer A), 2.5 mM MUGlc and 
different amounts of lipid vesicles and/or Sap C as specified in the 
experiments. The effect of Sap C was also checked in the presence of 
Triton X-100, as previously reported [12,13]. In this case the assay 
mixture contained, in a final volume of 0.2 ml: 50 mM acetate buffer 
(pH 4.5) 2.5 mM MUGlc and 0.05% (v/v) Triton X-100. 
The assay mixtures were incubated for 30 min at 37°C. The extent 
of reaction was estimated fluorometrically. All assays were carried out 
in duplicate and agreed within 5%. 
1 U of glucosylceramidase i  defined as the amount of enzyme which 
hydrolyzes 1 nmol of MUGlc/h in the standard assay. 
2.6. Protein determination 
The proteins were measured with the bicinchoninic acid method [20] 
with bovine serum albumin as standard. 
2.7. Vesicle preparatron 
PS vesicles were prepared as previously described [16]. In short, 
small unilamellar vesicles (SUV) were obtained by submitting the lipid 
suspension to sonication under nitrogen in a Branson B 15 Sonifier, 
while large unilamellar vesicles (LUV) were prepared by filter exclu- 
sion through two stacked 0.1 pm pore size polycarbonate filters (Nu- 
cleopore Corp., Pleasanton, CA) using a high pressure xtrusion appa- 
ratus (Lipex Biomembranes Inc., Vancouver, BC). 
2.8. Chromatography on Bio-Gel A-50m columns 
To analyze the physical interaction of Sap C with lipid vesicles and 
glucosylceramidase, the samples were incubated for 15 min at 37“C 
in buffer A and then loaded on Bio-Gel A-50m columns (10 x 170 mm; 
Bio-Rad, Richmond, USA) preequilibrated and eluted with the same 
buffer. When the sample contained glucosylceramidase, the column 
was first eluted with 20 ml of buffer A and then with buffer containing 
2% (w/v) TC. A new column was used for each experiment. The flow 
rate was 0.3 ml/min for all columns. Fractions of 0.4 ml were collected. 
Chromatographic separations were carried out at room temperature. 
3. RESULTS AND DISCUSSION 
3.1. Effect of Sap C on glucosylceramidase activation by 
PS LUV 
We have previously shown that, at difference with PS 
SUV, PS LUV are unable to fully stimulate purified 
160 
glucosylceramidase [ 161. At a concentration of PS L W 
up to 10 lug/ml less than 10% of the activity measured 
in an assay medium containing either detergents (stand- 
ard assay, see section 2) or PS SUV was observed 
(Table I). Thus we have investigated the possibility of 
promoting enzyme activation by PS LUV with Sap C, 
a well-known glucosylceramidase activator [3,4]. As a 
matter of fact we have found that Sap C dramatically 
enhances the stimulating power of LUV (Fig. l), while 
it has a small effect on the activation exerted by SUV, 
by themselves able to efficiently stimulate the enzyme 
(Table I). The stimulation in the Sap C-PS LUV system 
is similar to the optimum obtained both in the standard 
and the PS SUV systems (Table I). In agreement with 
previous reports [4,11], Sap C alone is nearly uneffective 
on glucosylceramidase activity (Fig. 1 and Table I). The 
pH optimum of glucosylceramidase in the Sap C-PS 
LUV system is in the range 5.s5.4, slightly lower than 
that previously found when PS SUV were used as acti- 
vators (pH 5.8, Ref. [16]). 
Since several authors who have investigated the 
mechanism of glucosylceramidase activation by Sap C 
have included Triton X- 100 in the assay [ 12,131, we have 
compared the stimulation exerted by Sap C in the pres- 
ence of either PS LUV or Triton X-100. As shown in 
Table I the Sap C-PS LUV system is much more effi- 
cient than the Sap C-T&on X-100 system. Most prob- 
ably the stimulation mediated by the detergent is related 
with the reported formation of a high molecular weight 
complex containing Sap C and Triton X-100 micelles 
1211. 
3.2. Physical interaction between Sap C, PS LUV and 
glucosylceramidase 
In a previous paper it was shown that the low stimu- 
lation of PS LW depended on the poor interaction 
between this type of vesicles and glucosylceramidase 
[16]. The positive effect of Sap C on the PS LW stim- 
ulating ability suggested that this protein favoured in 
some way the phospholipid-enzyme interaction. Two 
mechanisms can be envisaged for this effect: either Sap 
Fig. 1. Effect of Sap C on the stimulation of glucosylceramidase 
activity by PS LUV. Different amounts of Sap C were added to 200 ~1 
buffer A containing 2.5 mM MUGlc and 25 U purified glucosylcer- 
amidase. Enzyme activity was measured either without further addi- 
tions (A) or in the presence of 10 &ml of PS LUV (0). 
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Table I 
Comparison of the effect of Sap C on glucosylceramidase activity 
under various conditions 
Enzyme activity (nmol/h) 
Conditions - Sap C + Sap C 
:: (PS LUV) 
0.6 1.5 
1.5 26 
3. (PS SUV) 24 28 
4. (Tri) 0.5 4 
5. (Tri-TC) 25 25 
Glucosylceramidase assays contained, in a final volume of 200 ~1, 
25 U of enzyme, 2.5 mM MUGlc and the following compounds. 1, 
buffer A; 2, buffer A and 2 pug PS LUV, 3, buffer A brought at pH 
5.8 and 2pg PS SUV; 4, acetate buffer 50 mM, pH 4.5 and 0.05% (v/v) 
Triton X-100; 5, citrate-phosphate buffer 0.1 M, pH 5.6, 0.1% (v/v) 
Triton X-100 and 0.25% (w/v) TC (standard system). Enzyme activity 
was measured in the absence or in the presence of 10 .&ml of Saposin 
C. The different buffers were chosen so as to obtain optimal stimula- 
tion under the various conditions. Abbreviations: Tri, Triton X-100; 
TC, taurocholate. 
C associates with PS LUV making the lipid surface 
more suitable for binding glucosylceramidase, or Sap C 
associates with the enzyme increasing the affinity of 
glucosylceramidase for PS LUV Evidence for complex 
formation between Sap C and either PS LUV or gluco- 
sylceramidase was sought by a previously used gel per- 
meation chromatographic technique [16]. As shown in 
Fig. 2A, Sap C elutes in the included volume and can 
activate glucosylceramidase only when PS LUV are 
added to the assay. On the contrary, Sap C, incubated 
with PS LUV before chromatography, coelutes with the 
phospholipid and fully stimulates the enzyme (Fig. 2B). 
The position of Sap C in the elution patterns was con- 
firmed by immunoblots of the column fractions with a 
Sap C monospecific antibody. 
Different to what happens with PS LUV, the elution 
of Sap C is not affected by previous incubation with 
glucosylceramidase. In fact, the mixture of the two pro- 
teins gives rise to well resolved peaks, one of Sap C 
eluting between fractions 25-40 (see Fig. 2A) and one 
of glucosylceramidase eluting between fractions 82-95 
(see Fig. 3). It thus appears that, if a complex between 
glucosylceramidase and Sap C is formed at all, it is 
much weaker than that between Sap C and PS LUV. 
Since on interaction with Sap C large PS liposomes 
acquire the capacity to reactivate glucosylceramidase, 
one can expect that likewise they become able to bind 
the enzyme. Actually, glucosylceramidase incubated 
with the PS LUV-Sap C complex coelutes with the 
phospholipid and the activator protein (Fig. 3). In the 
absence of Sap C, PS LUV and glucosylceramidase are 
completely separated, the enzyme being retained by the 
Bio-gel column, as previously reported [16]. 
Complex formation between saposins (A, B, C, D) 
and acidic phospholipids was previously excluded on 
the basis of experiments performed by incubating the 
water-soluble saposins with PS coated on Celite [13]. 
The lack of aqueous solubilization of PS was interpreted 
as lack of interaction between the protein activators and 
the lipid. The different experimental approaches fol- 
lowed by these authors and by us might explain the 
opposite conclusions that have been reached. 
Up to now the role of Sap C in the glucosylcerami- 
dase activation has been explained as the result of the 
activator protein binding to the enzyme [4,10,12,13] 
rather than to lipids. The main line of evidence for a 
direct binding of Sap C to glucosylceramidase was the 
observation that Sepharose-linked Sap C acted as an 
affinity column for the enzyme [12]. It must be noted 
that the enzyme loaded on the affinity column was not 
purified and that the elution buffer contained Triton 
X-100, a detergent that has a strong affinity for both the 
activator protein [21] and glucosylceramidase. Thus, 
binding of glucosylceramidase to the Sepharose-linked 
Sap C might in fact reflect interactions of the two pro- 
teins with some lipid present in the enzyme preparation 
or/and with Triton X-100. 
Frachon number 
Fig. 2. Physical interaction of Sap C with PS LUV analyzed by chrom- 
atography on Bio-Gel columns. Purified Sap C (25 pg) and PS LUV 
(80 pup) were loaded on Bio-Gel A-50m columns either separately (A) 
or after mixing with each other (B). Trace amounts of labelled [“‘C]PS 
was mixed with unlabelled PS prior to preparation of vesicles. The 
elution was performed as reported in section 2. The liposome distribu- 
tion (- -) was determined by measuring the radioactivity. The gluco- 
sylceramidase activation by Sap C was tested by incubating an aliquot 
of the fractions (50~1) with 150~1 buffer A containing 3.4 mM MUGlc 
and 25 U purified glucosylceramidase either in the absence (0) or in 
the presence of 10 &ml of PS LUV (w). The inserts show the im- 
munoblots of pooled fractions corresponding to the bars (1, fractions 
l&15; 2, fractions 2&25; 3, fractions 3&35). After SDS-PAGE anal- 
ysis and electophoretic transfer of proteins, Sap C was visualized with 
rabbit anti-Sap C (see section 2). When Sap C (25 pg) was incubated 
with glucosylceramidase (up to 10,000 U) instead of PS LUV, the 
elution pattern of the activator protein was identical to that shown in 
(A). 
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Fraction number 
Fig. 3. Physical interaction of glucosylceramidase with PS LUV in the 
presence or in the absence of Sap C. Purified glucosylceramidase 
(300&4000 U) was incubated with PS LUV (80,ug) in the absence (0) 
or in the presence (B) of 25 pug of Saposin C. The elution was per- 
formed as described in section 2. The arrow indicates when TC was 
added to the eluent. The distribution of PS vesicles (- -) was deter- 
mined as in Fig. 2. The glucosylceramidase elution was estimated 
measuring its activity according to the standard assay (see section 2). 
When glucosylceramidase was analyzed after incubation with Sap C 
in the absence of PS LUV the enzyme eluted from the column only 
after the addition of TC to the buffer (0). 
Sap C has a structure similar to that of the other three 
saposins (A, B, D). It was noted that there is also an 
extensive homology between the major pulmonary sur- 
factant-associated protein SP-B and the four saposins 
[10,22]. This homology raises the possibility that the 
mode of their action may also be similar. Saposin B 
(Sap B) has been shown to bind to various lipids includ- 
ing sulfatides and gangliosides [9]. Similarly to Sap B, 
pulmonary surfactant-associated protein SP-B binds 
lipids interacting selectively with phosphatidylglycerol 
[23]. Our finding that also the activity of Sap C depends 
on the interaction with appropriate lipids indicates that 
the similar structures of SP-B, Sap B and Sap C actually 
correspond to similar function; the properties of all of 
these depend on lipid binding. 
In conclusion our studies indicate that in some cases 
not only acidic phospholipids but also Sap C are re- 
quired for the glucosylceramidase binding to mem- 
branes. We propose that the glucosylceramidase stimu- 
lation by the protein activator derives from a facilitated 
binding of the enzyme to a membrane surface somehow 
modified by its interaction with Sap C. According to 
this model Sap C would be the first example of a sphin- 
golipid activator protein that acts by associating mainly 
with an activator lipid rather than with an enzyme or 
with a substrate. 
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